OncoImmune: Raises $56M Series B Financing
OncoImmune, Inc., a Rockville, Md.-based clinical-stage biopharmaceutical company, completed a $56m Series B equity financing
The round co-led by HM Capital and a...
© 2026 FintechInshorts. All Rights Reserved.

